Effect of an Oral Therapeutic Patient Education Session on Physical Activity in Patients With Cancer
ETAP
Effect of a Brief Therapeutic Patient Education Session on Physical Activity in Patients at the Onset of Cancer Therapy: A Randomized Controlled Trial
1 other identifier
interventional
98
1 country
1
Brief Summary
Despite significant evolution of cancer therapies from the early 20th century, these therapies are still associated with toxic effects that negatively impact the patient's performance status, quality of life and survival. The role of physical activity to counteract these side effects is acknowledged. However, cancer patients are often misinformed about the potential benefits of physical therapy during cancer therapy. In this context, the role of therapeutic patient education seems essential. Because of lack of time, therapeutic patient education (TPE) is often provided via an information booklet. However, the investigators assume that a face-to-face interview results in a greater impact on patient's behavior change (the level of physical activity during cancer therapy, in our case). This research project is designed to challenge this hypothesis. The investigators hypothesize that a brief oral educational session of 30 minutes provided at the very beginning of cancer therapy will enhance the physical activity level of our patients for at least 6 months, i.e. during their cancer therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Dec 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2020
CompletedStudy Start
First participant enrolled
December 7, 2020
CompletedFirst Posted
Study publicly available on registry
December 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 29, 2022
CompletedApril 17, 2024
April 1, 2024
1.6 years
December 7, 2020
April 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in PA level
The PA level will be estimated in MET/h/week via the International Physical Activity Questionnaire (long form) validated in French in subjects aged 18-84 years. The questionnaire classifies the subject according to 3 activity levels: inactive, moderate, high
At baseline and 6 months (at the occasion of a second follow-up visit set with the oncologist) after the start of the cancer therapy
Secondary Outcomes (8)
Changes in PA level
At baseline and 3 months (at the occasion of a first follow-up visit set with the oncologist) after the start of the cancer therapy
Changes in BMI
At baseline, 3 months and 6 months after the start of the cancer therapy
Changes in fatigue
At baseline, 3 months and 6 months after the start of the cancer therapy
Changes in quality of life
At baseline, 3 months and 6 months after the start of the cancer therapy
Changes in exercise capacity
At baseline, 3 months and 6 months after the start of the cancer therapy
- +3 more secondary outcomes
Study Arms (2)
Oral semi-structured interview
EXPERIMENTALThe oral semi-structured interview uses the principles of motivational interviewing (partnership with the patient, no judgment, altruism, evocation) and follow the content of the booklet used in the control group.
Booklet
ACTIVE COMPARATORThe information booklet was designed by the physiotherapists at Cliniques universitaires Saint-Luc and is specifically dedicated to raise patient's awareness about the benefits of physical activity (PA) in the context of cancer.
Interventions
The physiotherapist discusses and goes through each page of the booklet and involves the patient as much as possible. He demonstrates the exercises proposed in the booklet and then ask the patient to perform them in front of him. The physiotherapist tries to identify the patient's needs and suggests different ways to ensure that the patient has different opportunities to maintain the best possible level of PA
The booklet (11 pages): explains why it is important to maintain a good level of PA as part of cancer treatment and reviews the most common side effects of cancer therapy and the relative importance of PA in combating these effects (pages 2-3) ; defines PA, its modalities and possible security precautions (pages 4-5), suggests exercises to be performed oneself and a target intensity to be reached (pages 6-8), provides a roadmap to be completed oneself (pages 9-10), and outlines procedures for joining an exercise medicine group (page 11).
Eligibility Criteria
You may qualify if:
- Adults aged between 18 and 84 years
- Suffering from a first cancer, with the exception of the following cancers in the patient's history (provided that they have been successfully treated):
- non-melanoma skin cancer,
- carcinoma in situ of the uterine cervix
- ductal carcinoma in situ.
- Preserved performance status (ECOG scale ≤ 1),
- Starting one of the following systemic cancer therapies:
- chemotherapy,
- immunotherapy,
- targeted therapies,
- Able to understand and read French
- Life expectancy of at least 1 year
You may not qualify if:
- Poor cognitive function (Mini-Mental State Examination ≤ 24/30)
- Having a recurrence of cancer, with the exception of the following cancers in the patient's history (provided that they have been successfully treated):
- non-melanoma skin cancer,
- carcinoma in situ of the uterine cervix,
- ductal carcinoma in situ.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cliniques universitaires Saint-Luc
Brussels, 1200, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 7, 2020
First Posted
December 14, 2020
Study Start
December 7, 2020
Primary Completion
July 29, 2022
Study Completion
July 29, 2022
Last Updated
April 17, 2024
Record last verified: 2024-04